Withdrawal characteristics following chronic pentobarbital dosing

Area of Science:

• Pharmacology
• Neuroscience
• Veterinary Medicine

Background:

• Chronic administration of sedative-hypnotic drugs like sodium pentobarbital can lead to physical dependence.
• Barbiturate withdrawal syndrome is a significant clinical concern, necessitating detailed characterization.

Purpose of the Study:

• To quantitatively describe the barbiturate withdrawal syndrome in a feline model.
• To establish the time course, severity, and manifestations of barbiturate abstinence.
• To provide a basis for pre-clinical evaluation of sedative-hypnotic dependence treatments.

Main Methods:

• Physical dependence was induced in 63 cats using chronic, maximal tolerable doses of sodium pentobarbital over 5 weeks.
• Withdrawal signs were monitored in activity cages, with electroencephalographic (EEG) monitoring of sleep-wake cycles in 5 cats.
• Quantitative assessment of motor, autonomic, and seizure activity during the abstinence period.

Main Results:

• Withdrawal signs emerged within 12-18 hours post-cessation and rapidly intensified.
• Observed signs included significant neural hyperexcitability, motor disturbances, and autonomic dysfunction.
• Mortality rate was 41% (26 cats), often associated with generalized tonic-clonic (grand mal) seizures.

Conclusions:

• Quantitative data on barbiturate withdrawal are essential for understanding dependence mechanisms.
• This study provides a detailed profile of barbiturate abstinence, aiding in the comparison of drug dependencies.
• The findings support the utility of this model for pre-clinical assessment of treatments for sedative-hypnotic drug dependence.